Recognise / red flags: Suspected ACS requires rapid ECG, clinical assessment and repeated ECGs if symptoms persist. A normal first ECG or troponin does not rule out evolving ACS.
Investigate / stratify: Distinguish STEMI requiring urgent reperfusion from NSTEMI/unstable angina risk pathways, using ECG, serial high-sensitivity troponin, clinical risk and haemodynamic status.
Initial management: NICE recommends an immediate 300 mg aspirin loading dose in STEMI/NSTEMI/unstable angina unless allergic. Primary PCI is preferred for suitable STEMI when timely. Antithrombotic selection differs between primary PCI, other interventions, medical management and patients already receiving anticoagulants.
Exam pitfall / safety: Avoid indiscriminate oxygen in non-hypoxaemic ACS. A generic “DAPT for 12 months” rule misses major individual bleeding/anticoagulation considerations.

Source checked 2026-10-30: NICE NG185. Focused teaching summary only; historical material below has not had a full dose-by-dose review. Use current BNF, local guidelines and specialist advice for individual patients.

⚡ ST elevation changes everything! → urgent coronary reperfusion required. 📉 A 12-lead ECG must be performed within 10 minutes of arrival for suspected ACS. 👵 Large myocardial infarctions may be silent in elderly or diabetic patients. 🫀 Early reperfusion saves myocardium → primary PCI is the preferred treatment.

🚑 Immediate Assessment of Suspected ACS (First 10 Minutes)
📋 Rapid clinical assessment + NEWS + continuous cardiac monitoring 📈 12-lead ECG within 10 minutes (repeat if ongoing pain or first ECG nondiagnostic) 💉 IV access + bloods (troponin, FBC, U&E, glucose) 🫁 Oxygen only if SpO₂ <94% (target 94–98%) 💊 Aspirin 300 mg PO immediately (chewed) 💊 GTN 400 micrograms SL if blood pressure stable 💉 Morphine 1–2 mg IV aliquots if severe pain + antiemetic ➕ Add P2Y12 inhibitor: Used + Aspirin as DAPT. Usually 12 months, individualised for bleeding risk and any concurrent anticoagulant (NICE NG185). ⚡ Ticagrelor commonly preferred in ACS because of faster and more potent platelet inhibition. 🛑 Clopidogrel may be used if ticagrelor is contraindicated or bleeding risk is high. ⛔ Prasugrel when PCI is planned. High bleed risk. C/I TIA/stroke/age>75/Wt < 60 kg. 💉 Start anticoagulation if NSTEMI pathway (e.g. fondaparinux) 💊 Atorvastatin 80 mg as early as possible ⚡ ST elevation → activate primary PCI pathway immediately

🚑 Immediate Assessment of Suspected ACS (First 10 Minutes)

📋 Rapid clinical assessment + NEWS + continuous cardiac monitoring
📈 12-lead ECG within 10 minutes (repeat if ongoing pain or first ECG nondiagnostic)
💉 IV access + bloods (troponin, FBC, U&E, glucose)
🫁 Oxygen only if SpO₂ <94% (target 94–98%)
💊 Aspirin 300 mg PO immediately (chewed)
💊 GTN 400 micrograms SL if blood pressure stable
💉 Morphine 1–2 mg IV aliquots if severe pain + antiemetic
➕ Add P2Y12 inhibitor: Used + Aspirin as DAPT. Usually 12 months, individualised for bleeding risk and any concurrent anticoagulant (NICE NG185).

⚡ Ticagrelor commonly preferred in ACS because of faster and more potent platelet inhibition.
🛑 Clopidogrel may be used if ticagrelor is contraindicated or bleeding risk is high.
⛔ Prasugrel when PCI is planned. High bleed risk. C/I TIA/stroke/age>75/Wt < 60 kg.

💉 Start anticoagulation if NSTEMI pathway (e.g. fondaparinux)
💊 Atorvastatin 80 mg as early as possible
⚡ ST elevation → activate primary PCI pathway immediately

📖About

ACS describes a spectrum of conditions caused by acute myocardial ischaemia due to coronary plaque rupture and thrombosis. ACS includes unstable angina, NSTEMI, and STEMI. 📈 The ECG differentiates STEMI (urgent reperfusion required) from NSTEMI/unstable angina. 🧪 A rise and/or fall in troponin confirms myocardial injury.

🧬 Aetiology

Most cases of acute coronary syndrome (ACS) occur when an atherosclerotic plaque ruptures or erodes within a coronary artery. This exposes thrombogenic material from the lipid core to circulating blood, triggering platelet activation, aggregation, and thrombus formation. The resulting clot reduces or blocks coronary blood flow, producing the spectrum of unstable angina, NSTEMI, or STEMI depending on the degree and duration of occlusion. Less common causes include coronary artery spasm, spontaneous coronary artery dissection, coronary embolism, and oxygen supply–demand mismatch (e.g. severe anaemia, sepsis, or tachyarrhythmia). Understanding this mechanism explains why ACS treatment focuses on antiplatelet therapy, anticoagulation, and rapid reperfusion.

🎓 Exam Tips

🧠 Most ACS events are caused by plaque rupture with thrombosis – this is the classic exam answer.
⚡ STEMI usually reflects complete coronary occlusion, whereas NSTEMI often reflects partial occlusion.
🧪 A diagnosis of myocardial infarction requires a rise and/or fall in troponin plus evidence of myocardial ischaemia.
⚠️ Not all troponin elevations represent ACS – think about Type 2 myocardial infarction (e.g. sepsis, PE, tachyarrhythmia).
📈 Early ECG changes may be subtle – repeat ECGs are essential if symptoms persist.

🔎 Types of Acute Coronary Syndrome

🟡 Unstable angina → ischaemic symptoms without troponin elevation
🟠 NSTEMI → myocardial necrosis without ST elevation
🔴 STEMI → transmural infarction with ST elevation

📊 NSTEMI vs STEMI

	NSTEMI	STEMI
📉 ECG	ST depression / T wave inversion	ST elevation
🩸 Coronary occlusion	Subtotal occlusion	Complete occlusion
⚰ Mortality	Lower early mortality	Higher early mortality
💉 Thrombolysis	❌ Not indicated	✅ Used if PCI unavailable

⚠️ Aetiology

🟢 Most ACS results from rupture or erosion of an atherosclerotic plaque.
🩸 Platelet activation and thrombus formation reduce coronary blood flow.
⏱️ “Time = muscle” → delayed reperfusion worsens myocardial damage.

🧬 Pathophysiology

🔓 Plaque rupture exposes thrombogenic material.
🧬 Platelets aggregate and activate the coagulation cascade.
⛔ Coronary blood flow decreases → myocardial ischaemia.
💔 Persistent occlusion leads to irreversible myocardial necrosis.

📑 Universal Classification of MI

⚠️ Not all troponin elevations represent coronary thrombosis. Type 2 myocardial infarction occurs when oxygen supply–demand mismatch causes myocardial injury.

Type	Description
1	Plaque rupture causing coronary thrombosis
2	Supply–demand mismatch (e.g. anaemia, sepsis, tachyarrhythmia)
3	Sudden cardiac death before biomarkers available
4	PCI-related MI
5	CABG-related MI

⚠️ Risk Factors

👨 Age >40 (men) or >50 (women)
🚬 Smoking
🍔 Dyslipidaemia
💉 Diabetes
⬆ Hypertension
🧬 Family history of premature coronary disease

🩺 Clinical Presentation

🚨 Central crushing chest pain radiating to arm or jaw
😰 Sweating, nausea, feeling of impending doom
👵 Elderly or diabetic patients may present atypically
🫀 Signs of heart failure or cardiogenic shock in severe infarction

⚠️ Atypical Presentations may be seen in older adults, women, and patients with diabetes. Symptoms may include breathlessness, epigastric discomfort, nausea, vomiting, fatigue, dizziness, or syncope rather than obvious chest pain. Some patients describe only indigestion-like discomfort, jaw pain, or isolated arm pain. Diabetic patients may develop silent myocardial ischaemia due to autonomic neuropathy, resulting in minimal or absent pain despite significant myocardial injury. Because atypical presentations are common in high-risk groups, clinicians should maintain a low threshold for performing an ECG and checking troponin when evaluating unexplained acute symptoms.

🧪 Investigations

12-lead ECG within 10 minutes
High-sensitivity troponin at presentation and repeat after 1–3 hours
Blood tests: FBC, U&E, glucose
Chest X-ray to exclude other pathology
Echocardiography if haemodynamic instability or complications suspected

🫀 Management of Acute Coronary Syndrome

Management priorities: 1️⃣ Rapid diagnosis 2️⃣ Relieve myocardial ischaemia 3️⃣ Prevent thrombus propagation 4️⃣ Restore coronary perfusion

💊 Immediate Treatment

Drug	Typical Dose	Purpose
Aspirin	300 mg PO stat	Platelet inhibition
P2Y12 inhibitor	Ticagrelor 180 mg PO	Dual antiplatelet therapy
GTN	400 micrograms SL	Relieve myocardial ischaemia
Morphine	1–2 mg IV aliquots	Pain relief
Anticoagulant	Fondaparinux 2.5 mg SC	Prevent thrombus propagation
Statin	Atorvastatin 80 mg	Plaque stabilisation

⚡ Reperfusion Strategy

Primary PCI is the preferred treatment for STEMI.
If PCI cannot be delivered promptly → consider thrombolysis.
High-risk NSTEMI → early invasive coronary angiography.

⚠️ Complications of ACS

⚡ Ventricular arrhythmias (VT/VF)
💔 Cardiogenic shock
🫀 Heart failure
🧬 Mechanical rupture (papillary muscle, septum)
🧫 Pericarditis

💊 Secondary Prevention

🛡 Beta-blocker (once haemodynamically stable)
💊 Atorvastatin 80 mg
💊 ACE inhibitor
💊 Dual antiplatelet therapy
🚭 Smoking cessation
🥗 Lifestyle modification + cardiac rehabilitation

🧠 Advanced Clinical Insights (High-Yield)

These concepts are frequently tested in clinical exams and help explain real-world ACS management decisions.

Troponin Interpretation

Troponin elevation indicates myocardial injury, not necessarily coronary thrombosis.
Diagnosis of MI requires troponin rise/fall plus evidence of ischaemia.
Common non-ACS causes include sepsis, pulmonary embolism, myocarditis, tachyarrhythmia, and renal failure.

ECG Evolution in STEMI

Hyperacute T waves
ST elevation
Pathological Q waves
T-wave inversion

Posterior Myocardial Infarction

Often presents with ST depression in V1–V3
Tall R waves may be seen
Posterior leads (V7–V9) may reveal ST elevation

Right Ventricular Infarction

Usually occurs with inferior MI due to RCA occlusion
Features: hypotension, clear lungs, raised JVP
Diagnosis confirmed with right-sided ECG leads
Management: avoid nitrates; give cautious IV fluids

📚 References

💡 Clinical Pearl The most common early cause of death in acute MI is ventricular arrhythmia. Rapid ECG diagnosis and immediate reperfusion remain the most important life-saving steps in ACS management.

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Acute Coronary Syndrome (ACS): Chest Pain ❤️

Acute coronary syndrome — initial pathway